FOI 1221 – Information Commissioner review – Special Arrangement for Opiate Dependence Treatment Program

This FOI request relates to the supply of pharmaceutical benefits for the purpose of treating opiate dependence.

Downloads

FOI 1221 – Information Commissioner review – Special Arrangement for Opiate Dependence Treatment Program

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

FOI number:
1221-2024
FOI release date:
Publication type:
Report
Audience:
General public
Description:

This request looks at the special arrangements in which the Australian Government funds the cost of buprenorphine, buprenorphine with naloxone and methadone supplied as pharmaceutical benefits through clinics and pharmacies approved by state and territory governments.

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.